Page last updated: 2024-11-02

oxymetazoline and Lacrimal Duct Obstruction

oxymetazoline has been researched along with Lacrimal Duct Obstruction in 1 studies

Oxymetazoline: A direct acting sympathomimetic used as a vasoconstrictor to relieve nasal congestion. (From Martindale, The Extra Pharmacopoeia, 30th ed, p1251)
oxymetazoline : A member of the class of phenols that is 2,4-dimethylphenol which is substituted at positions 3 and 6 by 4,5-dihydro-1H-imidazol-2-ylmethyl and tert-butyl groups, respectively. A direct-acting sympathomimetic with marked alpha-adrenergic activity, it is a vasoconstrictor that is used (generally as the hydrochloride salt) to relieve nasal congestion.

Lacrimal Duct Obstruction: Interference with the secretion of tears by the lacrimal glands. Obstruction of the LACRIMAL SAC or NASOLACRIMAL DUCT causing acute or chronic inflammation of the lacrimal sac (DACRYOCYSTITIS). It is caused also in infants by failure of the nasolacrimal duct to open into the inferior meatus and occurs about the third week of life. In adults occlusion may occur spontaneously or after injury or nasal disease. (Newell, Ophthalmology: Principles and Concepts, 7th ed, p250)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Cabanis, EA1
Coulombel, P1
Cavezian, R1
Bleynie, D1
Danicel, V1
Bernard, JA1

Other Studies

1 other study available for oxymetazoline and Lacrimal Duct Obstruction

ArticleYear
[Value of a new functional dacryocystography test--discussion].
    Bulletin des societes d'ophtalmologie de France, 1982, Volume: 82, Issue:4

    Topics: Aged; Female; Humans; Lacrimal Apparatus; Lacrimal Duct Obstruction; Nasal Decongestants; Oxymetazol

1982